Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ:DMAA
Want to see DMAA full AI Analyst Report?
| Dec 25 | Dec 24 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 |
| Operating Income | $ -2.82M | $ -479.00 |
| EBITDA | $ -2.82M | $ 0.00 |
| Net Income | $ 5.94M | $ -479.00 |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 6.14K | $ 1.35K |
| Total Assets | $ 239.92M | $ 551.00 |
| Total Debt | $ 0.00 | $ 662.00 |
| Net Debt | $ -6.14K | $ 661.00 |
| Total Liabilities | $ 7.28M | $ 796.00 |
| Stockholders' Equity | $ 232.64M | $ -244.00 |
| Cash Flow | ||
| Free Cash Flow | $ -539.19K | $ -295.00 |
| Operating Cash Flow | $ -539.19K | $ -295.00 |
| Investing Cash Flow | $ -231.15M | $ 0.00 |
| Financing Cash Flow | $ 231.69M | $ 173.62K |
Drugs Made In America Acquisition Corp. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.